Intensity-Modulated Radiotherapy with a Simultaneous Integrated Boost Combined with Chemotherapy in Stages III-IV Hypopharynx-Larynx Cancer: Treatment Compliance and Clinical Outcomes
Figure 3
Freedom from relapse of 60 patients with hypopharyngeal-laryngeal cancer by site (A = hypopharyngeal versus B = laryngeal cancer).